SSE PLC
SCRIP DIVIDEND SCHEME
The Board of SSE plc ('the Company') confirms that the Scrip reference price for the fully paid ordinary shares to be issued to shareholders electing to receive the Scrip dividend alternative for the interim dividend for the year ending 31 March 2022, payable on 10 March 2022, will be 1,579 pence per share.
The Scrip reference price has been calculated by taking the average mid-market closing price of the Company's shares over the five business days commencing on the ex-dividend date. In respect of the interim dividend for the year ending 31 March 2022, this was the period 13 to 19 January 2022.
If all of the Company's eligible shareholders as at the record date of 14 January 2022 were to elect to participate in the Scrip Dividend Scheme in respect of their entire shareholdings as at such date, based on the Scrip reference price of 1,579 pence per share, the maximum number of shares required to be issued by the Company, for Scrip dividend purposes, would be 1,065,831,345 representing approximately 1.6% of the Company's issued share capital (excluding treasury shares) on the record date.
The exact number of shares which will require to be issued will be established after 10 February 2022, the final date for receipt of elections to participate in the Scrip Dividend Scheme.
Shareholders wishing to participate in the Scrip Dividend Scheme should contact Link Group and return their mandate forms to arrive no later than 10 February 2022. Shareholders wishing to withdraw from the Scrip Dividend Scheme should ensure their requests to withdraw are lodged with Link Group to arrive no later than 10 February 2022.
Shareholders who hold their shares in uncertificated form should consult their Crest sponsors as appropriate.
Scrip dividend timetable for the interim dividend for the year ending 31 March 2022
Ex-dividend date 13 January 2022
Record date 14 January 2022
Scrip reference price calculation period 13 - 19 January 2022
Last date for receipt of Scrip elections 10 February 2022
Dividend payment/Scrip issue date 10 March 2022